Maxime Dely: How Plasma Exchange Treats Severe Diseases – “A Simple Act Behind a Complex Therapy”
Maxime Dely, Sales and Application Specialist in Therapeutic Apheresis and Cell Therapy, shared a post on LinkedIn:
“Plasma: the invisible therapy that’s already transforming modern medicine!
Plasma exchanges play a crucial role today in treating many severe conditions. Performed using apheresis, they remove harmful components from the patient’s plasma… a highly technical procedure with often remarkable results.
And for this therapy to exist, one key element is essential: albumin.
A protein available exclusively thanks to plasma donations. Without donors, plasma exchanges simply cannot happen.
A major therapeutic tool
Plasma exchanges are used to treat:
• Autoimmune diseases (myasthenia gravis, Guillain-Barré syndrome…)
• Hematological disorders
• Severe neurological conditions
• Kidney diseases
• Complex immunological disorders
This technique removes autoantibodies, toxins or immune complexes that drive the disease.
Looking ahead: incredible new prospects
Recent studies suggest that plasma exchanges may slow the progression of Alzheimer’s disease, opening the door to new approaches for neurodegenerative conditions.
A promising field that could reshape the future of care for millions of patients.
A simple act behind a complex therapy
Plasma exchanges require large amounts of albumin.
Albumin comes only from plasma donors.
Every donation makes these treatments possible.
A heartfelt thank you to all donors: your generosity saves lives every single day.”
Get the latest from Hemostasis Today.
-
Oct 27, 2026, 05:58Cedric Hermans: An Evening of Cinema in Support of Blood Disorder Research
-
Oct 27, 2026, 04:56Ayodeji Olayanju: Why Choose between a Transfusion and Haemoglobinopathy CPD When You Can Do Both?
-
Oct 27, 2026, 04:54Aisha Suala: When One Underfilled Tube Can Mislead the Entire Laboratory Result
-
Oct 27, 2026, 04:34Incremental Mobility and Venous Thromboembolism Risk in Hospitalized Medical Patients – JTH
-
Oct 27, 2026, 04:29Matthew Hazell: From Rare Blood to AI – Reflecting on Three Days of Innovation at AABB 2026
-
Oct 27, 2026, 04:24Khairul Missa Mohd Amin: Highlights from RANZCR ASM 2026 and Building Stronger PE Care
-
Oct 27, 2026, 04:14Pedro Perez: Why the Future of PE Care Demands Individualized Strategy
-
Oct 27, 2026, 04:09Hari Trivedi: Real-World AI Performance in PE Detection
-
Oct 27, 2026, 03:50Nathalie Conrad: Uncovering 30-Year Sex Differences Across 55 ESC Nations